Age-dependent acceleration of ischemic injury in endothelial nitric oxide synthase-deficient mice: Potential role of impaired VEGF receptor 2 expression

被引:22
作者
Qian, Hu Sheng
Monterio de Resende, Micheline
Beausejour, Christian
Huw, Ling-Yuh
Liu, Perry
Rubanyi, Gabor. M.
Kauser, Katalin
机构
[1] Berlex Biosci, Dept Pharmacol, Richmond, CA USA
[2] Berlex Biosci, Dept Cardiovasc, Richmond, CA USA
[3] Berlex Biosci, Gene Therapy Res Dept, Richmond, CA USA
关键词
hindlimb ischemia; VEGF; ecNOS; Shh; angiogenesis;
D O I
10.1097/01.fjc.0000211736.55583.5c
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Morbidity and mortality of peripheral arterial occlusive disease significantly increases with age, often exhibiting more severe disease pathology and decreased treatment effectiveness. Therapeutic angiogenesis with angiogenic growth factors may represent a valuable treatment option for the severely ill, older adult patient population. Aging is considered an independent cardiovascular risk factor, but pathomechanistically it is not well understood. Diminished endothelial nitric oxide (EDNO) production has been considered as a major contributor to the aging process. To investigate the effect of age on postischemic revascularization independent of changes in EDNO, we used endothelial nitric oxide synthase-deficient (ecNOS-KO) mice. We found an age-dependent acceleration in ischemic injury following unilateral femoral artery ligation ill these animals compared to C57BL/J6 mice. Postischemic revascularization, quantified by measuring von Willebrand factor expression, was significantly impaired, suggesting that factors other than progressive EDNO deterioration are also involved in the age-dependent severe disease phenotype. Ischemia led to an increase in the expression of vascular endothelial growth factor receptor-2, KDR, in younger ecNOSKO; however, this increase in KDR expression was absent in the older animals. Lack of increased KDR expression may provide a mechanistic explanation for the severe ischemic injury and perhaps can be used as a clinical marker to identify severe, vascular endothelial growth factor refractory patient population.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 20 条
[1]
EFFECTS OF AGING ON QUANTITATIVE STRUCTURAL-PROPERTIES OF CORONARY VASCULATURE AND MICROVASCULATURE IN RATS [J].
ANVERSA, P ;
LI, P ;
SONNENBLICK, EH ;
OLIVETTI, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (03) :H1062-H1073
[2]
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease [J].
Boger, RH ;
BodeBoger, SM ;
Thiele, W ;
Junker, W ;
Alexander, K ;
Frolich, JC .
CIRCULATION, 1997, 95 (08) :2068-2074
[3]
Couffinhal T, 1998, AM J PATHOL, V152, P1667
[4]
Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice [J].
Couffinhal, T ;
Silver, M ;
Kearney, M ;
Sullivan, A ;
Witzenbichler, B ;
Magner, M ;
Annex, B ;
Peters, K ;
Isner, JM .
CIRCULATION, 1999, 99 (24) :3188-3198
[5]
Phosphorylation of the endothelial nitric oxide synthase at Ser-1177 is required for VEGF-induced endothelial cell migration [J].
Dimmeler, S ;
Dernbach, E ;
Zeiher, AM .
FEBS LETTERS, 2000, 477 (03) :258-262
[6]
Selective inhibition of vascular endothelial growth factor receptor-2 (VEGXR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF [J].
Endo, A ;
Fukuhara, S ;
Masuda, M ;
Ohmori, T ;
Mochizuki, N .
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2003, 23 (2-3) :239-254
[7]
Genetic background influences therapeutic effectiveness of VEGF [J].
Fukino, K ;
Sata, M ;
Seko, Y ;
Hirata, Y ;
Nagai, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (01) :143-147
[8]
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [J].
Fulton, D ;
Gratton, JP ;
McCabe, TJ ;
Fontana, J ;
Fujio, Y ;
Walsh, K ;
Franke, TF ;
Papapetropoulos, A ;
Sessa, WC .
NATURE, 1999, 399 (6736) :597-601
[9]
Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans [J].
Gerhard, M ;
Roddy, MA ;
Creager, SJ ;
Creager, MA .
HYPERTENSION, 1996, 27 (04) :849-853
[10]
KAUSER K, 2002, MECH VASCULOPROTECTI, P1